These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 23073318

  • 1. Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors.
    Tsai MS, Hung CC, Liu WC, Chen KL, Chen MY, Hsieh SM, Sheng WH, Sun HY, Shih TT.
    J Microbiol Immunol Infect; 2014 Apr; 47(2):109-15. PubMed ID: 23073318
    [Abstract] [Full Text] [Related]

  • 2. Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors.
    Shaiykova A, Pasquet A, Goujard C, Lion G, Durand E, Bayan T, Lachâtre M, Choisy P, Ajana F, Bourdic K, Viget N, Riff B, Quertainmont Y, Cortet B, Boufassa F, Chéret A.
    AIDS; 2018 Nov 28; 32(18):2689-2696. PubMed ID: 30234605
    [Abstract] [Full Text] [Related]

  • 3. Monitoring early developed low bone mineral density in HIV-infected patients by intact parathyroid hormone and circulating fibroblast growth factor 23.
    Chen KY, Wang CH, Lin TY, Chang CY, Liu CL, Hsiao YC, Hung CC, Wang NC.
    J Microbiol Immunol Infect; 2019 Oct 28; 52(5):693-699. PubMed ID: 30293926
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
    Mazzotta E, Ursini T, Agostinone A, Di Nicola AD, Polilli E, Sozio F, Vadini F, Pieri A, Trave F, De Francesco V, Capasso L, Borderi M, Manzoli L, Viale P, Parruti G.
    AIDS Patient Care STDS; 2015 Apr 28; 29(4):169-80. PubMed ID: 25692868
    [Abstract] [Full Text] [Related]

  • 5. Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.
    Brown TT, Ruppe MD, Kassner R, Kumar P, Kehoe T, Dobs AS, Timpone J.
    J Clin Endocrinol Metab; 2004 Mar 28; 89(3):1200-6. PubMed ID: 15001610
    [Abstract] [Full Text] [Related]

  • 6. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL, Lai PSM, Tan ATB, Ponnampalavanar S.
    Osteoporos Int; 2018 Mar 28; 29(3):595-613. PubMed ID: 29159533
    [Abstract] [Full Text] [Related]

  • 7. Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.
    Assoumou L, Katlama C, Viard JP, Bentata M, Simon A, Roux C, Kolta S, Costagliola D, Rozenberg S, ANRS Osteovir study group.
    AIDS; 2013 Sep 24; 27(15):2425-30. PubMed ID: 24029735
    [Abstract] [Full Text] [Related]

  • 8. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, Mercié P, Morlat P, Thiébaut R, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    AIDS; 2008 Jan 30; 22(3):395-402. PubMed ID: 18195566
    [Abstract] [Full Text] [Related]

  • 9. High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy.
    Escota GV, Mondy K, Bush T, Conley L, Brooks JT, Önen N, Patel P, Kojic EM, Henry K, Hammer J, Wood KC, Lichtenstein KA, Overton ET.
    AIDS Res Hum Retroviruses; 2016 Jan 30; 32(1):59-67. PubMed ID: 26366785
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
    Al-Shoumer KA, Nair V.
    Arch Osteoporos; 2012 Jan 30; 7():147-53. PubMed ID: 23225292
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and associated factors of low bone mineral density in people living with HIV: a cross-sectional study.
    Shao Y, Sun J, Kong K, Zhang R, Zhang R, Liu L, Wang J, Shen Y, Wu L, Zheng Z, Sun M, Qi T, Wang Z, Tang Y, Sun J, Song W, Yang J, Xu S, Zhao B, Shan F, Qin A, Lu H, Chen J.
    Arch Osteoporos; 2024 Jul 02; 19(1):56. PubMed ID: 38954143
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.
    Puthanakit T, Saksawad R, Bunupuradah T, Wittawatmongkol O, Chuanjaroen T, Ubolyam S, Chaiwatanarat T, Nakavachara P, Maleesatharn A, Chokephaibulkit K.
    J Acquir Immune Defic Syndr; 2012 Dec 01; 61(4):477-83. PubMed ID: 22918157
    [Abstract] [Full Text] [Related]

  • 13. Long-term use of protease inhibitors is associated with bone mineral density loss.
    Kinai E, Nishijima T, Mizushima D, Watanabe K, Aoki T, Honda H, Yazaki H, Genka I, Tanuma J, Teruya K, Tsukada K, Gatanaga H, Kikuchi Y, Oka S.
    AIDS Res Hum Retroviruses; 2014 Jun 01; 30(6):553-9. PubMed ID: 24494779
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Carr A, Grund B, Neuhaus J, Schwartz A, Bernardino JI, White D, Badel-Faesen S, Avihingsanon A, Ensrud K, Hoy J, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.
    HIV Med; 2015 Apr 01; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332
    [Abstract] [Full Text] [Related]

  • 15. Relative contribution of HIV infection, demographics and body mass index to bone mineral density.
    Cotter AG, Sabin CA, Simelane S, Macken A, Kavanagh E, Brady JJ, McCarthy G, Compston J, Mallon PW, HIV UPBEAT Study Group.
    AIDS; 2014 Sep 10; 28(14):2051-60. PubMed ID: 25265073
    [Abstract] [Full Text] [Related]

  • 16. Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.
    Krikke M, Klomberg RCW, van der Veer E, Tesselaar K, Verhaar HJJ, Hoepelman AIM, Arends JE.
    Neth J Med; 2017 May 10; 75(4):138-144. PubMed ID: 28522769
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study.
    Zeng YQ, Xiao J, Li CL, Wang Y, Zhang L, Pang XL, Wang D, Du J, Zhao HX.
    Chin Med J (Engl); 2020 Dec 03; 133(24):2940-2946. PubMed ID: 33278100
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of bone mineral density abnormalities and related risk factors in an ambulatory HIV clinic population.
    Guillemi S, Harris M, Bondy GP, Ng F, Zhang W, Lima VD, Michaels CE, Belzberg A, Montaner JS.
    J Clin Densitom; 2010 Dec 03; 13(4):456-61. PubMed ID: 20663695
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study.
    Bonjoch A, Figueras M, Estany C, Perez-Alvarez N, Rosales J, del Rio L, di Gregorio S, Puig J, Gómez G, Clotet B, Negredo E, Osteoporosis Study Group.
    AIDS; 2010 Nov 27; 24(18):2827-33. PubMed ID: 21045635
    [Abstract] [Full Text] [Related]

  • 20. Low bone mass prevalence, therapy type, and clinical risk factors in an HIV-infected Brazilian population.
    Pinto Neto LF, Ragi-Eis S, Vieira NF, Soprani M, Neves MB, Ribeiro-Rodrigues R, Miranda AE.
    J Clin Densitom; 2011 Nov 27; 14(4):434-9. PubMed ID: 22051092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.